| SS-Chr 13BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
resting on treadmill (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82.0 days-99.0 days |
7 |
|
|
33.13 |
mmHg |
0.67 |
1.77 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14465 |
381 |
| SS-Chr 13BN/Mcwi |
minute ventilation |
controlled air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
9 |
|
|
78.63 |
ml/min |
4.93 |
14.79 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14507 |
381 |
| SS-Chr 13BN/Mcwi |
heart rate |
controlled air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
7 |
|
|
419.34 |
beats/min |
15.43 |
40.82 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14712 |
381 |
| SS-Chr 13BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
7 |
|
|
456.56 |
beats/min |
10.43 |
27.59 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15942 |
381 |
| SS-Chr 13BN/Mcwi |
tidal volume |
controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
0.32 |
ml |
0.05 |
0.14 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15240 |
381 |
| SS-Chr 13BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
9 |
|
|
97.17 |
breaths/min |
3.37 |
10.1 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14947 |
381 |
| SS-Chr 13BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
male |
80.0 days-99.0 days |
18 |
|
|
143.27 |
mmHg |
0.95 |
4.05 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52855 |
482 |
| SS-Chr 13BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
female |
80.0 days-99.0 days |
20 |
|
|
0.76 |
mEq/d |
0.05 |
0.24 |
flame atomic emission spectrometry |
|
|
|
|
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52949 |
482 |
| SS-Chr 13BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
female |
80.0 days-99.0 days |
17 |
|
|
1.13 |
ng/ml/h |
0.29 |
1.2 |
radioimmunoassay |
|
|
|
|
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52457 |
482 |
| SS-Chr 13BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
male |
80.0 days-99.0 days |
16 |
|
|
75.43 |
mg/d |
8.18 |
32.71 |
automated urine total protein analysis |
|
|
|
|
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52706 |
482 |
| SS-Chr 13BN/Mcwi |
percent change in respiration rate |
controlled air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
9 |
|
|
170.28 |
% |
6.62 |
19.86 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
54234 |
381 |
| SS-Chr 13BN/Mcwi |
mean arterial blood pressure |
controlled air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
8 |
|
|
116.97 |
mmHg |
2.46 |
6.96 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
13506 |
381 |
| SS-Chr 13BN/Mcwi |
body temperature |
controlled air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
9 |
|
|
37.99 |
degrees C |
0.24 |
0.73 |
digital rectal thermometry |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
13566 |
381 |
| SS-Chr 13BN/Mcwi |
percent change in ventilation |
controlled air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
9 |
%change=VE during7-9 min hypercapnia/control during standard conditions |
|
253.41 |
% |
22.58 |
67.74 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14205 |
381 |
| SS-Chr 13BN/Mcwi |
mean arterial blood pressure |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
8 |
|
|
120.5 |
mmHg |
4.3 |
12.17 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14352 |
381 |
| SS-Chr 13BN/Mcwi |
blood pH |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
female |
82.0 days-99.0 days |
7 |
|
|
7.54 |
null |
0.02 |
0.05 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
17063 |
381 |
| SS-Chr 13BN/Mcwi |
respiration rate |
controlled air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
9 |
|
|
156.39 |
breaths/min |
4.99 |
14.96 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
17118 |
381 |
| SS-Chr 13BN/Mcwi |
heart rate |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
9 |
|
|
488.0 |
beats/min |
17.43 |
52.29 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
13792 |
381 |
| SS-Chr 13BN/Mcwi |
tidal volume |
controlled air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
0.34 |
ml |
0.05 |
0.15 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
13930 |
381 |
| SS-Chr 13BN/Mcwi |
absolute change in blood pH |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
male |
82.0 days-99.0 days |
8 |
|
|
0.07 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19806 |
381 |
| SS-Chr 13BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
8 |
|
|
114.63 |
mmHg |
2.94 |
8.31 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19887 |
381 |
| SS-Chr 13BN/Mcwi |
minute ventilation |
controlled air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
9 |
|
|
67.71 |
ml/min |
3.81 |
11.43 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20768 |
381 |
| SS-Chr 13BN/Mcwi |
percent change in respiration rate |
controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
9 |
|
|
120.16 |
% |
8.49 |
25.46 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
53768 |
381 |
| SS-Chr 13BN/Mcwi |
mean arterial blood pressure |
resting on treadmill (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
7 |
|
|
99.45 |
mmHg |
3.74 |
9.9 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20048 |
381 |
| SS-Chr 13BN/Mcwi |
blood pH |
resting on treadmill (for 0.1 hours) |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
male |
82.0 days-99.0 days |
7 |
|
|
7.45 |
null |
0.01 |
0.03 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
20154 |
381 |
| SS-Chr 13BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
female |
82.0 days-99.0 days |
8 |
|
|
7.47 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20638 |
381 |
| SS-Chr 13BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
male |
82.0 days-99.0 days |
9 |
|
|
275.0 |
g |
7.6 |
22.8 |
whole body digital scale |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17829 |
381 |
| SS-Chr 13BN/Mcwi |
body temperature |
resting on treadmill (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
10 |
|
|
38.02 |
degrees C |
0.13 |
0.42 |
digital rectal thermometry |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18121 |
381 |
| SS-Chr 13BN/Mcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
male |
82.0 days-99.0 days |
8 |
|
|
108.43 |
mmHg |
2.84 |
8.03 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18889 |
381 |
| SS-Chr 13BN/Mcwi |
mean arterial blood pressure |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
7 |
|
|
119.25 |
mmHg |
4.64 |
12.28 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18941 |
381 |
| SS-Chr 13BN/Mcwi |
serum total protein level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77.0 days-91.0 days |
12 |
|
|
6.57 |
g/dl |
0.04 |
0.15 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36969 |
401 |
| SS-Chr 13BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
12 |
|
|
32.13 |
g/dl |
0.11 |
0.39 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37362 |
401 |
| SS-Chr 13BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
9 |
|
|
38.04 |
degrees C |
0.23 |
0.7 |
digital rectal thermometry |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19081 |
381 |
| SS-Chr 13BN/Mcwi |
minute ventilation |
controlled air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
41.73 |
ml/min |
5.93 |
18.74 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18669 |
381 |
| SS-Chr 13BN/Mcwi |
heart rate |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
8 |
|
|
417.99 |
beats/min |
12.93 |
36.58 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
17525 |
381 |
| SS-Chr 13BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
11 |
|
|
145.55 |
mmol/l |
0.41 |
1.37 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36533 |
401 |
| SS-Chr 13BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
11 |
|
|
9.56 |
mg/dl |
0.14 |
0.48 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36802 |
401 |
| SS-Chr 13BN/Mcwi |
absolute change in partial pressure of blood oxygen |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood oxygen amount |
female |
82.0 days-99.0 days |
7 |
|
|
-48.86 |
mmHg |
3.58 |
9.48 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19478 |
381 |
| SS-Chr 13BN/Mcwi |
respiration rate |
controlled air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
9 |
|
|
131.42 |
breaths/min |
8.08 |
24.24 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18277 |
381 |
| SS-Chr 13BN/Mcwi |
time to onset of heart contraction |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
male |
49.0 days-63.0 days |
19 |
|
|
956.68 |
s |
47.46 |
206.88 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49311 |
461 |
| SS-Chr 13BN/Mcwi |
time to onset of heart contraction |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
male |
49.0 days-63.0 days |
17 |
|
|
913.59 |
s |
42.45 |
175.02 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
50131 |
461 |
| SS-Chr 13BN/Mcwi |
time to peak heart contraction |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49.0 days-63.0 days |
19 |
|
|
1214.0 |
s |
37.6 |
163.9 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
50239 |
461 |
| SS-Chr 13BN/Mcwi |
serum chloride level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77.0 days-91.0 days |
11 |
|
|
109.73 |
mmol/l |
1.0 |
3.32 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39129 |
401 |
| SS-Chr 13BN/Mcwi |
red blood cell count |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
12 |
|
|
8.95 |
x 10E6 cells/ul |
0.12 |
0.42 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39244 |
401 |
| SS-Chr 13BN/Mcwi |
blood monocyte count |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77.0 days-91.0 days |
12 |
|
|
0.33 |
x 1000 cells/ul |
0.06 |
0.2 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39681 |
401 |
| SS-Chr 13BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77.0 days-91.0 days |
12 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42917 |
401 |
| SS-Chr 13BN/Mcwi |
serum total bilirubin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77.0 days-91.0 days |
11 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42926 |
401 |
| SS-Chr 13BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
77.0 days-91.0 days |
12 |
|
|
22.33 |
mmol/l |
0.63 |
2.19 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43024 |
401 |
| SS-Chr 13BN/Mcwi |
percent change in respiration rate |
controlled air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
9 |
|
|
130.79 |
% |
9.3 |
27.9 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
54341 |
381 |
| SS-Chr 13BN/Mcwi |
mean corpuscular hemoglobin concentration |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
12 |
|
|
32.0 |
g/dl |
0.23 |
0.8 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39784 |
401 |
| SS-Chr 13BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
12 |
|
|
106.25 |
mmol/l |
0.51 |
1.76 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40040 |
401 |
| SS-Chr 13BN/Mcwi |
serum chloride level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
male |
77.0 days-91.0 days |
11 |
|
|
105.27 |
mmol/l |
0.47 |
1.56 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40049 |
401 |
| SS-Chr 13BN/Mcwi |
percent change in respiration rate |
controlled air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
9 |
|
|
170.0 |
% |
5.32 |
15.95 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
53649 |
381 |
| SS-Chr 13BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
12 |
|
|
19.13 |
pg |
0.09 |
0.32 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40232 |
401 |
| SS-Chr 13BN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77.0 days-91.0 days |
11 |
|
|
3.92 |
g/dl |
0.04 |
0.12 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40450 |
401 |
| SS-Chr 13BN/Mcwi |
serum globulin level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77.0 days-91.0 days |
12 |
|
|
2.38 |
g/dl |
0.03 |
0.1 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
Moms and pups used in studies were fed Teklad |
40557 |
401 |
| SS-Chr 13BN/Mcwi |
serum urea nitrogen level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
77.0 days-91.0 days |
12 |
|
|
17.5 |
mg/dl |
0.6 |
2.07 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40835 |
401 |
| SS-Chr 13BN/Mcwi |
fractional change in blood vessel diameter per unit change in intravascular pressure |
Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
blood vessel distensibility trait |
male |
77.0 days-91.0 days |
10 |
|
|
0.06 |
mmHg-1 |
0.01 |
0.02 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59401 |
526 |
| SS-Chr 13BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
11 |
|
|
57.09 |
U/l |
3.58 |
11.89 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37750 |
401 |
| SS-Chr 13BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
12 |
|
|
43.72 |
% |
0.55 |
1.89 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41336 |
401 |
| SS-Chr 13BN/Mcwi |
plasma anion gap |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
77.0 days-91.0 days |
11 |
|
|
27.73 |
mmol/l |
1.87 |
6.2 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38273 |
401 |
| SS-Chr 13BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77.0 days-91.0 days |
11 |
|
|
0.01 |
x 1000 cells/ul |
0.01 |
0.02 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41447 |
401 |
| SS-Chr 13BN/Mcwi |
blood lymphocyte count |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77.0 days-91.0 days |
12 |
|
|
4.25 |
x 1000 cells/ul |
0.18 |
0.64 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41510 |
401 |
| SS-Chr 13BN/Mcwi |
blood eosinophil count |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77.0 days-91.0 days |
12 |
|
|
0.04 |
x 1000 cells/ul |
0.01 |
0.05 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41654 |
401 |
| SS-Chr 13BN/Mcwi |
serum glucose level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77.0 days-91.0 days |
12 |
|
|
155.25 |
mg/dl |
6.01 |
20.82 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38537 |
401 |
| SS-Chr 13BN/Mcwi |
time to peak heart contraction |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49.0 days-63.0 days |
10 |
|
|
1221.8 |
s |
39.17 |
123.87 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
46555 |
461 |
| SS-Chr 13BN/Mcwi |
percent change in left ventricular systolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49.0 days-63.0 days |
14 |
post-ischemic value/pre-ischemic value x 100% |
|
66.77 |
% |
8.5 |
31.81 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
48768 |
461 |
| SS-Chr 13BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
9 |
|
|
36.33 |
% |
2.58 |
7.75 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57258 |
522 |
| SS-Chr 13BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70.0 days-84.0 days |
15 |
|
|
0.87 |
g/mg |
0.1 |
0.38 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57359 |
522 |
| SS-Chr 13BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
9 |
|
|
27.9 |
ml/min |
2.13 |
6.39 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16154 |
381 |
| SS-Chr 13BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70.0 days-84.0 days |
11 |
|
|
176.4 |
g |
10.8 |
35.8 |
whole body digital scale |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55439 |
522 |
| SS-Chr 13BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77.0 days-91.0 days |
11 |
|
|
0.26 |
null |
0.01 |
0.03 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57944 |
526 |
| SS-Chr 13BN/Mcwi |
body temperature |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
9 |
|
|
37.44 |
degrees C |
0.14 |
0.43 |
digital rectal thermometry |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16584 |
381 |
| SS-Chr 13BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
8 |
|
|
-6.79 |
null |
0.06 |
0.17 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55650 |
522 |
| SS-Chr 13BN/Mcwi |
methylene blue to FAPGG metabolism-surface area product ratio |
controlled air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77.0 days-91.0 days |
11 |
|
|
0.42 |
null |
0.02 |
0.07 |
isolated perfused lung vascular effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58120 |
526 |
| SS-Chr 13BN/Mcwi |
FAPGG metabolism-surface area product |
FAPGG (0.6 mmol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77.0 days-91.0 days |
9 |
|
|
55.95 |
ml/min/kg |
3.58 |
10.73 |
isolated perfused lung vascular effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58260 |
526 |
| SS-Chr 13BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
9 |
|
|
38.11 |
degrees C |
0.22 |
0.65 |
digital rectal thermometry |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16824 |
381 |
| SS-Chr 13BN/Mcwi |
maximum contractile force per wet weight of aorta |
potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70.0 days-84.0 days |
11 |
|
|
1.71 |
g/mg |
0.08 |
0.27 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55813 |
522 |
| SS-Chr 13BN/Mcwi |
maximum contractile force per wet weight of aorta |
potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70.0 days-84.0 days |
9 |
|
|
1.37 |
g/mg |
0.08 |
0.24 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55822 |
522 |
| SS-Chr 13BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
11 |
|
|
276.2 |
g |
8.7 |
28.7 |
whole body digital scale |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58381 |
526 |
| SS-Chr 13BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70.0 days-84.0 days |
15 |
|
|
0.08 |
umol/l |
0.03 |
0.12 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
54931 |
522 |
| SS-Chr 13BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
10 |
|
|
35.0 |
% |
3.65 |
11.56 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55050 |
522 |
| SS-Chr 13BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
9 |
|
|
23.78 |
% |
3.7 |
11.1 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55056 |
522 |
| SS-Chr 13BN/Mcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
11 |
|
|
99.18 |
% |
0.4 |
1.33 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
56470 |
522 |
| SS-Chr 13BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
8 |
|
|
-6.77 |
null |
0.04 |
0.12 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
56949 |
522 |
| SS-Chr 13BN/Mcwi |
heart weight to body weight ratio |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
22 |
|
|
5.62 |
g/kg |
0.13 |
0.63 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
45641 |
461 |
| SS-Chr 13BN/Mcwi |
heart weight to body weight ratio |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
19 |
|
|
5.34 |
g/kg |
0.16 |
0.71 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
45650 |
461 |
| SS-Chr 13BN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
17 |
|
|
6.79 |
ml/min/g |
0.39 |
1.6 |
isolated perfused heart effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
44730 |
461 |
| SS-Chr 13BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
10 |
|
|
4.9 |
g/kg |
0.1 |
0.31 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47016 |
461 |
| SS-Chr 13BN/Mcwi |
left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
9 |
|
|
52.15 |
mmHg |
2.81 |
8.42 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47918 |
461 |
| SS-Chr 13BN/Mcwi |
left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
9 |
|
|
109.49 |
mmHg |
2.87 |
8.62 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
44822 |
461 |
| SS-Chr 13BN/Mcwi |
percent change in left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
|
80.95 |
% |
5.11 |
13.51 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
44925 |
461 |
| SS-Chr 13BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
10 |
|
|
4.8 |
ml/min/g |
0.52 |
1.63 |
isolated perfused heart effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
46208 |
461 |
| SS-Chr 13BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
17 |
|
|
6.09 |
ml/min/g |
0.36 |
1.48 |
isolated perfused heart effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
46213 |
461 |
| SS-Chr 13BN/Mcwi |
left ventricular diastolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
16 |
|
|
5.4 |
mmHg |
0.25 |
1.0 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47204 |
461 |
| SS-Chr 13BN/Mcwi |
heart rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49.0 days-63.0 days |
17 |
|
|
226.19 |
beats/min |
6.24 |
25.74 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
45155 |
461 |
| SS-Chr 13BN/Mcwi |
left ventricular developed pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
17 |
|
|
52.0 |
mmHg |
7.09 |
29.23 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
45282 |
461 |
| SS-Chr 13BN/Mcwi |
body weight |
control condition |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
body mass |
male |
49.0 days-63.0 days |
15 |
|
|
294.8 |
g |
8.3 |
32.15 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
99005 |
2198 |
| SS-Chr 13BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (0.4 %) (for 68 days) then controlled sodium content diet (8 %) (for 21 days) |
Moreno C, et al., Am J Physiol Heart Circ Physiol. 2011 Apr;300(4):H1530-5. doi: 10.1152/ajpheart.01026.2010. Epub 2011 Jan 21. |
arterial blood pressure trait |
male |
89.0 days
| 8 |
|
serial mean |
146.0 |
mmHg |
6.0 |
16.97 |
intra-aortic abdominal radiotelemetry via femoral cannulation |
|
10800.0 |
|
|
|
|
|
|
98672 |
2138 |
| SS-Chr 13BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (0.4 %) (for 68 days) then controlled sodium content diet (8 %) (for 21 days) |
Moreno C, et al., Am J Physiol Heart Circ Physiol. 2011 Apr;300(4):H1530-5. doi: 10.1152/ajpheart.01026.2010. Epub 2011 Jan 21. |
total urine protein amount |
male |
89.0 days
| 9 |
|
|
162.0 |
mg/d |
24.0 |
72.0 |
Bradford protein assay |
|
1.0 |
|
|
|
|
|
|
98686 |
2138 |
| SS-Chr 13BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
10 |
|
|
119.15 |
mmHg |
2.18 |
6.89 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15107 |
381 |
| SS-Chr 13BN/Mcwi |
absolute change in body temperature |
controlled air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
9 |
|
|
0.21 |
degrees C |
0.31 |
0.93 |
digital rectal thermometry |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15676 |
381 |
| SS-Chr 13BN/Mcwi |
blood pH |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (for 0.1 hours) |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
female |
82.0 days-99.0 days |
10 |
|
|
7.45 |
null |
0.01 |
0.03 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
14593 |
381 |
| SS-Chr 13BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
8 |
|
|
429.15 |
beats/min |
16.44 |
46.5 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15949 |
381 |
| SS-Chr 13BN/Mcwi |
absolute change in body temperature |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (for 0.1 hours) then running on treadmill (1.6 m/min) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
7 |
|
|
0.11 |
degrees C |
0.29 |
0.78 |
digital rectal thermometry |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16003 |
381 |
| SS-Chr 13BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
female |
80.0 days-99.0 days |
18 |
|
|
1.39 |
ml/min |
0.09 |
0.38 |
urine creatinine analysis |
|
|
|
|
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52163 |
482 |
| SS-Chr 13BN/Mcwi |
creatinine clearance |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
glomerular filtration trait |
male |
80.0 days-99.0 days |
15 |
|
|
2.38 |
ml/min |
0.23 |
0.87 |
urine creatinine analysis |
|
|
|
|
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52167 |
482 |
| SS-Chr 13BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
male |
80.0 days-99.0 days |
17 |
|
|
0.33 |
mg/dl |
0.02 |
0.08 |
radioimmunoassay |
|
|
|
|
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52216 |
482 |
| SS-Chr 13BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
male |
80.0 days-99.0 days |
18 |
|
|
382.3 |
beats/min |
2.75 |
11.69 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52657 |
482 |
| SS-Chr 13BN/Mcwi |
percent change in tidal volume |
controlled air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
172.11 |
% |
5.61 |
16.82 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
54100 |
381 |
| SS-Chr 13BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (for 0.1 hours) |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82.0 days-99.0 days |
7 |
|
|
29.14 |
mmHg |
0.44 |
1.15 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
13428 |
381 |
| SS-Chr 13BN/Mcwi |
body temperature |
controlled air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
9 |
|
|
37.76 |
degrees C |
0.21 |
0.64 |
digital rectal thermometry |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
13571 |
381 |
| SS-Chr 13BN/Mcwi |
mean arterial blood pressure |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
10 |
|
|
108.1 |
mmHg |
6.38 |
20.19 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14345 |
381 |
| SS-Chr 13BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood gas amount |
male |
82.0 days-99.0 days |
8 |
|
|
26.36 |
mmHg |
0.52 |
1.47 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
17262 |
381 |
| SS-Chr 13BN/Mcwi |
percent change in ventilation |
controlled air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
%change=VE during 2-3 min hypoxia/control during standard conditions |
|
156.19 |
% |
12.44 |
37.33 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
13692 |
381 |
| SS-Chr 13BN/Mcwi |
minute ventilation |
controlled air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
73.85 |
ml/min |
5.29 |
15.87 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20773 |
381 |
| SS-Chr 13BN/Mcwi |
absolute change in partial pressure of blood carbon dioxide |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82.0 days-99.0 days |
7 |
|
|
-3.99 |
mmHg |
0.36 |
0.94 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20082 |
381 |
| SS-Chr 13BN/Mcwi |
absolute change in partial pressure of blood carbon dioxide |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82.0 days-99.0 days |
8 |
|
|
-6.64 |
mmHg |
0.69 |
1.94 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19654 |
381 |
| SS-Chr 13BN/Mcwi |
heart rate |
resting on treadmill (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
10 |
|
|
431.31 |
beats/min |
14.74 |
46.62 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
17735 |
381 |
| SS-Chr 13BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
0.28 |
ml |
0.03 |
0.11 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
17989 |
381 |
| SS-Chr 13BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
0.28 |
ml |
0.03 |
0.09 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
17994 |
381 |
| SS-Chr 13BN/Mcwi |
mean arterial blood pressure |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
9 |
|
|
110.29 |
mmHg |
4.18 |
12.53 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18936 |
381 |
| SS-Chr 13BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
female |
77.0 days-91.0 days |
12 |
|
|
4.4 |
x 1000 cells/ul |
0.32 |
1.12 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36903 |
401 |
| SS-Chr 13BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
11 |
|
|
6.2 |
g/dl |
0.08 |
0.26 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37241 |
401 |
| SS-Chr 13BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77.0 days-91.0 days |
12 |
|
|
116.75 |
U/l |
7.95 |
27.53 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37484 |
401 |
| SS-Chr 13BN/Mcwi |
serum calcium level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
male |
77.0 days-91.0 days |
11 |
|
|
9.87 |
mg/dl |
0.1 |
0.32 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36636 |
401 |
| SS-Chr 13BN/Mcwi |
respiration rate |
controlled air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
10 |
|
|
123.41 |
breaths/min |
8.67 |
27.43 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18272 |
381 |
| SS-Chr 13BN/Mcwi |
heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49.0 days-63.0 days |
9 |
|
|
187.34 |
beats/min |
10.73 |
32.18 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
48952 |
461 |
| SS-Chr 13BN/Mcwi |
left ventricular diastolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
15 |
|
|
5.28 |
mmHg |
0.27 |
1.05 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49189 |
461 |
| SS-Chr 13BN/Mcwi |
time to onset of heart contraction |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
female |
49.0 days-63.0 days |
21 |
|
|
967.9 |
s |
27.23 |
124.76 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49306 |
461 |
| SS-Chr 13BN/Mcwi |
mean corpuscular hemoglobin |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
11 |
|
|
19.75 |
pg |
0.25 |
0.82 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42557 |
401 |
| SS-Chr 13BN/Mcwi |
serum sodium level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77.0 days-91.0 days |
12 |
|
|
145.33 |
mmol/l |
0.73 |
2.53 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39395 |
401 |
| SS-Chr 13BN/Mcwi |
serum sodium level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
male |
77.0 days-91.0 days |
11 |
|
|
145.64 |
mmol/l |
1.04 |
3.44 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39400 |
401 |
| SS-Chr 13BN/Mcwi |
serum aspartate aminotransferase activity level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77.0 days-91.0 days |
11 |
|
|
79.27 |
U/l |
8.27 |
27.43 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42782 |
401 |
| SS-Chr 13BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77.0 days-91.0 days |
12 |
|
|
5.03 |
x 1000 cells/ul |
0.34 |
1.17 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39919 |
401 |
| SS-Chr 13BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
male |
77.0 days-91.0 days |
11 |
|
|
22.91 |
mmol/l |
0.68 |
2.26 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43174 |
401 |
| SS-Chr 13BN/Mcwi |
blood neutrophil count |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77.0 days-91.0 days |
12 |
|
|
0.56 |
x 1000 cells/ul |
0.08 |
0.26 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43231 |
401 |
| SS-Chr 13BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
male |
77.0 days-91.0 days |
11 |
|
|
4.75 |
mmol/l |
0.11 |
0.37 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43370 |
401 |
| SS-Chr 13BN/Mcwi |
mean corpuscular hemoglobin |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
11 |
|
|
18.59 |
pg |
0.08 |
0.26 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40241 |
401 |
| SS-Chr 13BN/Mcwi |
serum albumin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
female |
77.0 days-91.0 days |
12 |
|
|
4.23 |
g/dl |
0.05 |
0.16 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40441 |
401 |
| SS-Chr 13BN/Mcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
female |
77.0 days-91.0 days |
11 |
|
|
1.39 |
mg/kg |
0.19 |
0.64 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59198 |
526 |
| SS-Chr 13BN/Mcwi |
hematocrit |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
12 |
|
|
55.92 |
% |
0.58 |
2.03 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59264 |
526 |
| SS-Chr 13BN/Mcwi |
serum urea nitrogen level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
11 |
|
|
18.73 |
mg/dl |
0.9 |
2.97 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40840 |
401 |
| SS-Chr 13BN/Mcwi |
total white blood cell count |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77.0 days-91.0 days |
11 |
|
|
6.53 |
x 1000 cells/ul |
0.41 |
1.37 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40938 |
401 |
| SS-Chr 13BN/Mcwi |
calculated pulmonary vascular resistance normalized to body weight |
controlled air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77.0 days-91.0 days |
12 |
|
|
0.15 |
mmHg x min x kg x ml-1 |
0.01 |
0.02 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59554 |
526 |
| SS-Chr 13BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77.0 days-91.0 days |
11 |
|
|
7.85 |
mg/dl |
0.16 |
0.52 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37861 |
401 |
| SS-Chr 13BN/Mcwi |
serum phosphate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77.0 days-91.0 days |
11 |
|
|
8.44 |
mg/dl |
0.11 |
0.37 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37870 |
401 |
| SS-Chr 13BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
female |
77.0 days-91.0 days |
12 |
|
|
2.04 |
g/dl |
0.03 |
0.11 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
Moms and pups used in studies were fed Teklad |
41061 |
401 |
| SS-Chr 13BN/Mcwi |
serum globulin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
male |
77.0 days-91.0 days |
11 |
|
|
2.28 |
g/dl |
0.05 |
0.18 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
Moms and pups used in studies were fed Teklad |
41070 |
401 |
| SS-Chr 13BN/Mcwi |
lung dry weight to body weight ratio |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
lung mass |
male |
77.0 days-91.0 days |
11 |
|
|
1.13 |
g/kg |
0.02 |
0.06 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59669 |
526 |
| SS-Chr 13BN/Mcwi |
lung dry weight to body weight ratio |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
lung mass |
female |
77.0 days-91.0 days |
12 |
|
|
1.48 |
g/kg |
0.05 |
0.16 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59664 |
526 |
| SS-Chr 13BN/Mcwi |
blood eosinophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
female |
77.0 days-91.0 days |
12 |
|
|
0.02 |
x 1000 cells/ul |
0.01 |
0.05 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41438 |
401 |
| SS-Chr 13BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
female |
77.0 days-91.0 days |
12 |
|
|
14.92 |
mg/dl |
0.7 |
2.43 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41786 |
401 |
| SS-Chr 13BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
11 |
|
|
57.45 |
fl |
0.2 |
0.65 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38690 |
401 |
| SS-Chr 13BN/Mcwi |
serum total bilirubin level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
female |
77.0 days-91.0 days |
12 |
|
|
0.11 |
mg/dl |
0.01 |
0.03 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41875 |
401 |
| SS-Chr 13BN/Mcwi |
serum total bilirubin level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood bilirubin amount |
male |
77.0 days-91.0 days |
11 |
|
|
0.1 |
mg/dl |
0.0 |
0.0 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41880 |
401 |
| SS-Chr 13BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
12 |
|
|
7.34 |
x 10E6 cells/ul |
0.1 |
0.33 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42003 |
401 |
| SS-Chr 13BN/Mcwi |
heart wet weight |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
22 |
|
|
0.87 |
g |
0.02 |
0.1 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
45412 |
461 |
| SS-Chr 13BN/Mcwi |
left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
7 |
|
|
139.47 |
mmHg |
6.72 |
17.78 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
45511 |
461 |
| SS-Chr 13BN/Mcwi |
left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
11 |
|
|
120.63 |
mmHg |
4.72 |
15.66 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
45516 |
461 |
| SS-Chr 13BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49.0 days-63.0 days |
21 |
|
|
0.44 |
IU/g |
0.06 |
0.28 |
isolated perfused heart effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47468 |
461 |
| SS-Chr 13BN/Mcwi |
percent change in left ventricular developed pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
11 |
post-ischemic value/pre-ischemic value x 100% |
|
49.11 |
% |
5.58 |
18.5 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
48534 |
461 |
| SS-Chr 13BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 1.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49.0 days-63.0 days |
9 |
|
|
30.61 |
IU/g |
3.05 |
9.15 |
isolated perfused heart effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
48888 |
461 |
| SS-Chr 13BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
11 |
|
|
43.48 |
% |
0.54 |
1.79 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57521 |
526 |
| SS-Chr 13BN/Mcwi |
absolute change in partial pressure of blood oxygen |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
blood oxygen amount |
male |
82.0 days-99.0 days |
7 |
|
|
12.43 |
mmHg |
4.63 |
12.25 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16285 |
381 |
| SS-Chr 13BN/Mcwi |
methylene blue metabolism-surface area product without auto-oxidation |
controlled air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77.0 days-91.0 days |
12 |
|
|
21.75 |
ml/min/kg |
0.55 |
1.92 |
isolated perfused lung vascular effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57807 |
526 |
| SS-Chr 13BN/Mcwi |
methylene blue metabolism-surface area product without auto-oxidation |
controlled air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77.0 days-91.0 days |
10 |
|
|
15.64 |
ml/min/kg |
0.45 |
1.41 |
isolated perfused lung vascular effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57812 |
526 |
| SS-Chr 13BN/Mcwi |
partial pressure of blood oxygen |
resting on treadmill (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
blood oxygen amount |
male |
82.0 days-99.0 days |
7 |
|
|
103.62 |
mmHg |
3.47 |
9.17 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16399 |
381 |
| SS-Chr 13BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77.0 days-91.0 days |
12 |
|
|
0.23 |
null |
0.01 |
0.04 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57935 |
526 |
| SS-Chr 13BN/Mcwi |
FAPGG metabolism-surface area product |
controlled air oxygen content (12 %) (for 14 days) then FAPGG (0.6 mmol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77.0 days-91.0 days |
11 |
|
|
52.49 |
ml/min/kg |
2.39 |
7.94 |
isolated perfused lung vascular effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58006 |
526 |
| SS-Chr 13BN/Mcwi |
body temperature |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
10 |
|
|
36.43 |
degrees C |
0.57 |
1.79 |
digital rectal thermometry |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16579 |
381 |
| SS-Chr 13BN/Mcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
10 |
|
|
0.04 |
10E-7mol/l |
0.01 |
0.03 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55740 |
522 |
| SS-Chr 13BN/Mcwi |
methylene blue to FAPGG metabolism-surface area product ratio |
controlled air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77.0 days-91.0 days |
10 |
|
|
0.42 |
null |
0.02 |
0.06 |
isolated perfused lung vascular effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58125 |
526 |
| SS-Chr 13BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
10 |
|
|
37.12 |
degrees C |
0.66 |
2.1 |
digital rectal thermometry |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16819 |
381 |
| SS-Chr 13BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
9 |
|
|
3.06 |
E-7mole |
0.56 |
1.67 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55928 |
522 |
| SS-Chr 13BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70.0 days-84.0 days |
11 |
|
|
0.02 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
54699 |
522 |
| SS-Chr 13BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70.0 days-84.0 days |
9 |
|
|
0.02 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
54708 |
522 |
| SS-Chr 13BN/Mcwi |
fractional change in blood vessel diameter per unit change in intravascular pressure |
controlled air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
blood vessel distensibility trait |
male |
77.0 days-91.0 days |
10 |
|
|
0.05 |
mmHg-1 |
0.0 |
0.01 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58501 |
526 |
| SS-Chr 13BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
14 |
|
|
89.5 |
% |
2.32 |
8.7 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
54805 |
522 |
| SS-Chr 13BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
10 |
|
|
26.2 |
% |
2.45 |
7.76 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55138 |
522 |
| SS-Chr 13BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
9 |
|
|
24.0 |
% |
2.43 |
7.28 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55144 |
522 |
| SS-Chr 13BN/Mcwi |
sodium nitroprusside-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
9 |
|
|
99.22 |
% |
0.57 |
1.72 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
56476 |
522 |
| SS-Chr 13BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
14 |
|
|
2.15 |
E-7mole |
0.98 |
3.66 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
56545 |
522 |
| SS-Chr 13BN/Mcwi |
methylene blue to FAPGG metabolism-surface area product ratio |
methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77.0 days-91.0 days |
9 |
|
|
0.37 |
null |
0.03 |
0.08 |
isolated perfused lung vascular effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59806 |
526 |
| SS-Chr 13BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
14 |
|
|
-7.03 |
null |
0.11 |
0.42 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
56940 |
522 |
| SS-Chr 13BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
8 |
|
|
47.38 |
% |
6.24 |
17.66 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57249 |
522 |
| SS-Chr 13BN/Mcwi |
tidal volume |
controlled air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
9 |
|
|
0.44 |
ml |
0.03 |
0.09 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
17377 |
381 |
| SS-Chr 13BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82.0 days-99.0 days |
8 |
|
|
33.38 |
mmHg |
0.89 |
2.53 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16082 |
381 |
| SS-Chr 13BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
10 |
|
|
10.15 |
ml/min/g |
0.64 |
2.02 |
isolated perfused heart effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
46877 |
461 |
| SS-Chr 13BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
|
48.23 |
% |
5.55 |
17.55 |
isolated perfused heart effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
46073 |
461 |
| SS-Chr 13BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
19 |
post-ischemic value/pre-ischemic value x 100% |
|
54.4 |
% |
2.4 |
10.47 |
isolated perfused heart effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47084 |
461 |
| SS-Chr 13BN/Mcwi |
heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49.0 days-63.0 days |
18 |
|
|
255.65 |
beats/min |
7.65 |
32.47 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
48209 |
461 |
| SS-Chr 13BN/Mcwi |
percent change in heart rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49.0 days-63.0 days |
17 |
post-ischemic value/pre-ischemic value x 100% |
|
89.31 |
% |
3.62 |
14.92 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
48302 |
461 |
| SS-Chr 13BN/Mcwi |
percent change in heart rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49.0 days-63.0 days |
19 |
post-ischemic value/pre-ischemic value x 100% |
|
76.6 |
% |
6.66 |
29.03 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
48307 |
461 |
| SS-Chr 13BN/Mcwi |
partial pressure of blood oxygen |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
blood oxygen amount |
female |
82.0 days-99.0 days |
10 |
|
|
116.11 |
mmHg |
3.7 |
11.71 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15039 |
381 |
| SS-Chr 13BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
9 |
|
|
0.29 |
ml |
0.02 |
0.05 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15404 |
381 |
| SS-Chr 13BN/Mcwi |
tidal volume |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
0.27 |
ml |
0.02 |
0.07 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15409 |
381 |
| SS-Chr 13BN/Mcwi |
minute ventilation |
controlled air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
75.71 |
ml/min |
4.77 |
14.3 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14512 |
381 |
| SS-Chr 13BN/Mcwi |
absolute change in body temperature |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (for 0.1 hours) then running on treadmill (1.6 m/min) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
10 |
|
|
0.38 |
degrees C |
0.19 |
0.59 |
digital rectal thermometry |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15998 |
381 |
| SS-Chr 13BN/Mcwi |
tidal volume |
controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
0.32 |
ml |
0.04 |
0.13 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15245 |
381 |
| SS-Chr 13BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
9 |
|
|
96.53 |
breaths/min |
7.4 |
22.2 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14942 |
381 |
| SS-Chr 13BN/Mcwi |
plasma creatinine level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
blood creatinine amount |
female |
80.0 days-99.0 days |
18 |
|
|
0.35 |
mg/dl |
0.02 |
0.07 |
radioimmunoassay |
|
|
|
|
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52212 |
482 |
| SS-Chr 13BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
male |
80.0 days-99.0 days |
16 |
|
|
10.59 |
mg/d |
2.08 |
8.32 |
radioimmunoassay |
|
|
|
|
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52606 |
482 |
| SS-Chr 13BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
female |
80.0 days-99.0 days |
20 |
|
|
8.83 |
mEq/d |
0.82 |
3.65 |
flame atomic emission spectrometry |
|
|
|
|
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52753 |
482 |
| SS-Chr 13BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (for 18 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
urine albumin amount |
male |
84.0 days-88.0 days |
12 |
|
|
21.4 |
mg/d |
3.0 |
10.39 |
urine analysis |
|
86400 |
|
|
|
|
|
|
65202 |
15 |
| SS-Chr 13BN/Mcwi |
heart rate |
controlled air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
8 |
|
|
375.78 |
beats/min |
13.65 |
38.61 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14719 |
381 |
| SS-Chr 13BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 16 and 19 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
arterial blood pressure trait |
female |
86.0 days-89.0 days |
12 |
|
|
137.0 |
mmHg |
1.9 |
6.58 |
vascular fluid filled catheter |
left femoral artery |
14400 |
|
|
|
on 3 consecutive days |
|
|
5403 |
15 |
| SS-Chr 13BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (for 0.1 hours) |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82.0 days-99.0 days |
10 |
|
|
29.12 |
mmHg |
0.74 |
2.35 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
13423 |
381 |
| SS-Chr 13BN/Mcwi |
mean arterial blood pressure |
controlled air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
7 |
|
|
112.41 |
mmHg |
5.67 |
15.0 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
13499 |
381 |
| SS-Chr 13BN/Mcwi |
respiration rate |
controlled air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
9 |
|
|
164.66 |
breaths/min |
6.41 |
19.22 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
17123 |
381 |
| SS-Chr 13BN/Mcwi |
heart rate |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
7 |
|
|
446.53 |
beats/min |
11.09 |
29.33 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
13797 |
381 |
| SS-Chr 13BN/Mcwi |
tidal volume |
controlled air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
0.34 |
ml |
0.05 |
0.14 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
13935 |
381 |
| SS-Chr 13BN/Mcwi |
absolute change in mean arterial blood pressure |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
9 |
|
|
13.36 |
mmHg |
2.76 |
8.29 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20721 |
381 |
| SS-Chr 13BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
8 |
|
|
438.51 |
beats/min |
17.08 |
48.32 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20943 |
381 |
| SS-Chr 13BN/Mcwi |
percent change in tidal volume |
controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
116.4 |
% |
9.12 |
28.83 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
53994 |
381 |
| SS-Chr 13BN/Mcwi |
blood pH |
resting on treadmill (for 0.1 hours) |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
female |
82.0 days-99.0 days |
10 |
|
|
7.47 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
20149 |
381 |
| SS-Chr 13BN/Mcwi |
body temperature |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (for 0.1 hours) then running on treadmill (1.6 m/min) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
7 |
|
|
38.34 |
degrees C |
0.26 |
0.7 |
digital rectal thermometry |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
17642 |
381 |
| SS-Chr 13BN/Mcwi |
body weight |
control condition |
PhysGen Respiratory data |
body mass |
female |
82.0 days-99.0 days |
11 |
|
|
185.9 |
g |
4.1 |
13.7 |
whole body digital scale |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Dyets |
17824 |
381 |
| SS-Chr 13BN/Mcwi |
body temperature |
resting on treadmill (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
7 |
|
|
38.23 |
degrees C |
0.09 |
0.24 |
digital rectal thermometry |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18126 |
381 |
| SS-Chr 13BN/Mcwi |
respiration rate |
controlled air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
9 |
|
|
174.09 |
breaths/min |
5.07 |
15.21 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16918 |
381 |
| SS-Chr 13BN/Mcwi |
partial pressure of blood oxygen |
control condition |
PhysGen Respiratory data |
blood oxygen amount |
female |
82.0 days-99.0 days |
8 |
|
|
105.78 |
mmHg |
3.8 |
10.76 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18882 |
381 |
| SS-Chr 13BN/Mcwi |
serum total protein level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
male |
77.0 days-91.0 days |
11 |
|
|
6.8 |
g/dl |
0.07 |
0.22 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36974 |
401 |
| SS-Chr 13BN/Mcwi |
serum total protein level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood total protein amount |
female |
77.0 days-91.0 days |
12 |
|
|
6.28 |
g/dl |
0.06 |
0.2 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37232 |
401 |
| SS-Chr 13BN/Mcwi |
body temperature |
control condition |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
9 |
|
|
37.78 |
degrees C |
0.23 |
0.68 |
digital rectal thermometry |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19076 |
381 |
| SS-Chr 13BN/Mcwi |
percent change in ventilation |
controlled air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
%change=VE during7-9 min hypercapnia/control during standard conditions |
|
138.16 |
% |
10.7 |
32.09 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18555 |
381 |
| SS-Chr 13BN/Mcwi |
serum calcium level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77.0 days-91.0 days |
12 |
|
|
9.39 |
mg/dl |
0.13 |
0.44 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36631 |
401 |
| SS-Chr 13BN/Mcwi |
serum calcium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood calcium amount |
female |
77.0 days-91.0 days |
12 |
|
|
9.33 |
mg/dl |
0.11 |
0.37 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36793 |
401 |
| SS-Chr 13BN/Mcwi |
minute ventilation |
controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
40.54 |
ml/min |
6.65 |
21.03 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20215 |
381 |
| SS-Chr 13BN/Mcwi |
absolute change in body temperature |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
10 |
|
|
-0.69 |
degrees C |
0.29 |
0.92 |
digital rectal thermometry |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20316 |
381 |
| SS-Chr 13BN/Mcwi |
absolute change in body temperature |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
9 |
|
|
-0.67 |
degrees C |
0.32 |
0.96 |
digital rectal thermometry |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20321 |
381 |
| SS-Chr 13BN/Mcwi |
partial pressure of blood oxygen |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood oxygen amount |
female |
82.0 days-99.0 days |
7 |
|
|
55.98 |
mmHg |
1.51 |
3.98 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20490 |
381 |
| SS-Chr 13BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
female |
49.0 days-63.0 days |
10 |
|
|
0.77 |
g |
0.03 |
0.09 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49067 |
461 |
| SS-Chr 13BN/Mcwi |
heart wet weight |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
18 |
|
|
0.95 |
g |
0.02 |
0.1 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49072 |
461 |
| SS-Chr 13BN/Mcwi |
heart left ventricle infarction weight to total heart left ventricle weight ratio |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) |
PhysGen Cardiac data |
heart left ventricle integrity trait |
female |
49.0 days-63.0 days |
10 |
|
|
14.85 |
% |
3.2 |
10.11 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49403 |
461 |
| SS-Chr 13BN/Mcwi |
body weight |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Cardiac data |
body mass |
female |
49.0 days-63.0 days |
22 |
|
|
155.1 |
g |
3.9 |
18.3 |
whole body digital scale |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49543 |
461 |
| SS-Chr 13BN/Mcwi |
left ventricular systolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
18 |
|
|
103.76 |
mmHg |
5.25 |
22.27 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49895 |
461 |
| SS-Chr 13BN/Mcwi |
heart contraction pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
female |
49.0 days-63.0 days |
21 |
|
|
46.52 |
mmHg |
2.69 |
12.35 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
50004 |
461 |
| SS-Chr 13BN/Mcwi |
time to peak heart contraction |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49.0 days-63.0 days |
21 |
|
|
1227.29 |
s |
32.5 |
148.91 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
50234 |
461 |
| SS-Chr 13BN/Mcwi |
mean corpuscular volume |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77.0 days-91.0 days |
12 |
|
|
62.52 |
fl |
0.39 |
1.35 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38752 |
401 |
| SS-Chr 13BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77.0 days-91.0 days |
11 |
|
|
0.89 |
x 1000 cells/ul |
0.06 |
0.21 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38939 |
401 |
| SS-Chr 13BN/Mcwi |
serum albumin level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
male |
77.0 days-91.0 days |
11 |
|
|
3.95 |
g/dl |
0.03 |
0.1 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42245 |
401 |
| SS-Chr 13BN/Mcwi |
hematocrit |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
11 |
|
|
57.16 |
% |
1.1 |
3.64 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39003 |
401 |
| SS-Chr 13BN/Mcwi |
red blood cell count |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
11 |
|
|
9.42 |
x 10E6 cells/ul |
0.14 |
0.46 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39249 |
401 |
| SS-Chr 13BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
male |
77.0 days-91.0 days |
11 |
|
|
86.45 |
U/l |
6.39 |
21.21 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42460 |
401 |
| SS-Chr 13BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77.0 days-91.0 days |
12 |
|
|
0.21 |
mg/dl |
0.01 |
0.03 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42680 |
401 |
| SS-Chr 13BN/Mcwi |
serum aspartate aminotransferase activity level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77.0 days-91.0 days |
12 |
|
|
73.08 |
U/l |
2.55 |
8.83 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42777 |
401 |
| SS-Chr 13BN/Mcwi |
plasma creatinine level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
female |
77.0 days-91.0 days |
12 |
|
|
0.27 |
mg/dl |
0.02 |
0.07 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39583 |
401 |
| SS-Chr 13BN/Mcwi |
total white blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
male |
77.0 days-91.0 days |
11 |
|
|
6.99 |
x 1000 cells/ul |
0.57 |
1.9 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39928 |
401 |
| SS-Chr 13BN/Mcwi |
plasma anion gap |
control condition (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
77.0 days-91.0 days |
12 |
|
|
20.83 |
mmol/l |
0.53 |
1.85 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43165 |
401 |
| SS-Chr 13BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
11 |
|
|
13.99 |
g/dl |
0.14 |
0.45 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40145 |
401 |
| SS-Chr 13BN/Mcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
controlled air oxygen content (12 %) (for 14 days) then methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
male |
77.0 days-91.0 days |
11 |
|
|
1.64 |
mg/kg |
0.21 |
0.7 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58918 |
526 |
| SS-Chr 13BN/Mcwi |
body weight |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
body mass |
female |
77.0 days-91.0 days |
12 |
|
|
176.6 |
g |
4.5 |
15.6 |
whole body digital scale |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59069 |
526 |
| SS-Chr 13BN/Mcwi |
serum alanine aminotransferase activity level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
male |
77.0 days-91.0 days |
11 |
|
|
50.91 |
U/l |
5.68 |
18.83 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40726 |
401 |
| SS-Chr 13BN/Mcwi |
serum alkaline phosphatase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77.0 days-91.0 days |
11 |
|
|
212.64 |
U/l |
11.48 |
38.06 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37493 |
401 |
| SS-Chr 13BN/Mcwi |
serum phosphate level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
female |
77.0 days-91.0 days |
12 |
|
|
8.2 |
mg/dl |
0.19 |
0.66 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37601 |
401 |
| SS-Chr 13BN/Mcwi |
serum phosphate level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood phosphate amount |
male |
77.0 days-91.0 days |
11 |
|
|
9.15 |
mg/dl |
0.18 |
0.58 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37606 |
401 |
| SS-Chr 13BN/Mcwi |
total white blood cell count |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
leukocyte quantity |
female |
77.0 days-91.0 days |
12 |
|
|
5.18 |
x 1000 cells/ul |
0.26 |
0.91 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40933 |
401 |
| SS-Chr 13BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
11 |
|
|
43.25 |
% |
0.47 |
1.57 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41345 |
401 |
| SS-Chr 13BN/Mcwi |
heart wet weight |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
19 |
|
|
1.01 |
g |
0.03 |
0.15 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
45417 |
461 |
| SS-Chr 13BN/Mcwi |
heart rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49.0 days-63.0 days |
21 |
|
|
251.89 |
beats/min |
7.46 |
34.17 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47589 |
461 |
| SS-Chr 13BN/Mcwi |
left ventricular developed pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
12 |
|
|
127.83 |
mmHg |
3.99 |
13.81 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
48631 |
461 |
| SS-Chr 13BN/Mcwi |
left ventricular developed pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
13 |
|
|
126.91 |
mmHg |
7.75 |
27.95 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
48636 |
461 |
| SS-Chr 13BN/Mcwi |
percent change in left ventricular systolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49.0 days-63.0 days |
14 |
post-ischemic value/pre-ischemic value x 100% |
|
83.16 |
% |
3.68 |
13.78 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
48763 |
461 |
| SS-Chr 13BN/Mcwi |
methylene blue metabolism-surface area product after auto-oxidation |
controlled air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) then sample resting period (for 0.1 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77.0 days-91.0 days |
10 |
|
|
11.35 |
ml/min/kg |
0.45 |
1.41 |
isolated perfused lung vascular effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57610 |
526 |
| SS-Chr 13BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70.0 days-84.0 days |
10 |
|
|
325.0 |
g |
8.1 |
25.6 |
whole body digital scale |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55213 |
522 |
| SS-Chr 13BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70.0 days-84.0 days |
9 |
|
|
-7.9 |
null |
0.09 |
0.28 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
55309 |
522 |
| SS-Chr 13BN/Mcwi |
tidal volume |
controlled air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
0.46 |
ml |
0.03 |
0.09 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16485 |
381 |
| SS-Chr 13BN/Mcwi |
FAPGG metabolism-surface area product |
controlled air oxygen content (12 %) (for 14 days) then FAPGG (0.6 mmol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77.0 days-91.0 days |
10 |
|
|
37.61 |
ml/min/kg |
1.89 |
5.98 |
isolated perfused lung vascular effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58011 |
526 |
| SS-Chr 13BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
28.32 |
ml/min |
3.23 |
9.69 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16702 |
381 |
| SS-Chr 13BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
26.71 |
ml/min |
3.41 |
10.78 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16697 |
381 |
| SS-Chr 13BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
8 |
|
|
1.75 |
E-7mole |
0.25 |
0.69 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55919 |
522 |
| SS-Chr 13BN/Mcwi |
FAPGG metabolism-surface area product |
FAPGG (0.6 mmol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77.0 days-91.0 days |
10 |
|
|
33.3 |
ml/min/kg |
2.05 |
6.5 |
isolated perfused lung vascular effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58269 |
526 |
| SS-Chr 13BN/Mcwi |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
10 |
|
|
-8.47 |
null |
0.08 |
0.26 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
54614 |
522 |
| SS-Chr 13BN/Mcwi |
logarithm of the concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
9 |
|
|
-8.2 |
null |
0.09 |
0.27 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
54620 |
522 |
| SS-Chr 13BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70.0 days-84.0 days |
15 |
|
|
-7.41 |
null |
0.12 |
0.47 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56130 |
522 |
| SS-Chr 13BN/Mcwi |
acetylcholine-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
8 |
|
|
65.63 |
% |
7.7 |
21.78 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
54814 |
522 |
| SS-Chr 13BN/Mcwi |
calculated pulmonary vascular resistance normalized to body weight |
Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77.0 days-91.0 days |
10 |
|
|
0.13 |
mmHg x min x kg x ml-1 |
0.01 |
0.02 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59931 |
526 |
| SS-Chr 13BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (0 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
female |
70.0 days-84.0 days |
10 |
|
|
51.4 |
% |
3.21 |
10.16 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57173 |
522 |
| SS-Chr 13BN/Mcwi |
left ventricular systolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
17 |
|
|
132.52 |
mmHg |
3.46 |
14.26 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
45736 |
461 |
| SS-Chr 13BN/Mcwi |
left ventricular systolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
14 |
|
|
134.84 |
mmHg |
6.73 |
25.19 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
45741 |
461 |
| SS-Chr 13BN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
21 |
|
|
12.34 |
ml/min/g |
0.35 |
1.63 |
isolated perfused heart effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
46660 |
461 |
| SS-Chr 13BN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
19 |
|
|
11.92 |
ml/min/g |
0.53 |
2.32 |
isolated perfused heart effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
46665 |
461 |
| SS-Chr 13BN/Mcwi |
left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
7 |
|
|
126.36 |
mmHg |
9.16 |
24.23 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
|
46757 |
461 |
| SS-Chr 13BN/Mcwi |
left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
11 |
|
|
111.69 |
mmHg |
5.61 |
18.6 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
|
46762 |
461 |
| SS-Chr 13BN/Mcwi |
left ventricular diastolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
17 |
|
|
53.74 |
mmHg |
4.1 |
16.92 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47713 |
461 |
| SS-Chr 13BN/Mcwi |
left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
17 |
|
|
45.84 |
mmHg |
4.42 |
18.21 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47923 |
461 |
| SS-Chr 13BN/Mcwi |
percent change in left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
|
90.56 |
% |
3.55 |
11.21 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
44930 |
461 |
| SS-Chr 13BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
19 |
post-ischemic value/pre-ischemic value x 100% |
|
52.69 |
% |
6.13 |
26.74 |
isolated perfused heart effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47089 |
461 |
| SS-Chr 13BN/Mcwi |
left ventricular diastolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
16 |
|
|
4.93 |
mmHg |
0.3 |
1.19 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47209 |
461 |
| SS-Chr 13BN/Mcwi |
percent change in left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
11 |
post-ischemic value/pre-ischemic value x 100% |
|
47.92 |
% |
5.55 |
18.41 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
46331 |
461 |
| SS-Chr 13BN/Mcwi |
left ventricular diastolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
18 |
|
|
45.68 |
mmHg |
3.88 |
16.47 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
46424 |
461 |
| SS-Chr 13BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49.0 days-63.0 days |
10 |
|
|
0.39 |
IU/g |
0.06 |
0.19 |
isolated perfused heart effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47332 |
461 |
| SS-Chr 13BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49.0 days-63.0 days |
17 |
|
|
0.34 |
IU/g |
0.03 |
0.14 |
isolated perfused heart effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47341 |
461 |
| SS-Chr 13BN/Mcwi |
percent change in heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49.0 days-63.0 days |
9 |
post-ischemic value/pre-ischemic value x 100% |
|
80.36 |
% |
3.88 |
11.63 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
48413 |
461 |
| SS-Chr 13BN/Mcwi |
extensor digitorum longus muscle weight to body weight ratio |
common peroneal nerve direct electrical stimulation (3 V) (for 8 hours) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56.0 days-70.0 days |
15 |
EDL/BW |
|
0.44 |
mg/g |
0.01 |
0.04 |
ex vivo method |
|
0.0 |
|
|
|
|
TA or EDL muscle weight body weight ratio |
|
99034 |
2198 |
| SS-Chr 13BN/Mcwi |
tibialis anterior muscle weight to body weight ratio |
control condition (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56.0 days-70.0 days |
15 |
TA/BW |
|
1.81 |
mg/g |
0.02 |
0.08 |
ex vivo method |
|
0.0 |
|
|
|
|
TA or EDL muscle weight body weight ratio |
|
99035 |
2198 |
| SS-Chr 13BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
8 |
|
|
120.02 |
mmHg |
2.02 |
5.71 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15114 |
381 |
| SS-Chr 13BN/Mcwi |
absolute change in body temperature |
controlled air carbon dioxide content (7 %) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
male |
82.0 days-99.0 days |
9 |
|
|
-0.29 |
degrees C |
0.16 |
0.48 |
digital rectal thermometry |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15681 |
381 |
| SS-Chr 13BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
resting on treadmill (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82.0 days-99.0 days |
10 |
|
|
31.59 |
mmHg |
0.88 |
2.78 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14460 |
381 |
| SS-Chr 13BN/Mcwi |
respiration rate |
controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
10 |
|
|
123.48 |
breaths/min |
6.22 |
19.68 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14801 |
381 |
| SS-Chr 13BN/Mcwi |
respiration rate |
controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
9 |
|
|
120.57 |
breaths/min |
7.13 |
21.4 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14806 |
381 |
| SS-Chr 13BN/Mcwi |
urine potassium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine potassium amount |
male |
80.0 days-99.0 days |
16 |
|
|
1.06 |
mEq/d |
0.09 |
0.35 |
flame atomic emission spectrometry |
|
|
|
|
|
urine potassium analysis |
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52953 |
482 |
| SS-Chr 13BN/Mcwi |
heart rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
heart pumping trait |
female |
80.0 days-99.0 days |
17 |
|
|
408.19 |
beats/min |
2.95 |
12.16 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52653 |
482 |
| SS-Chr 13BN/Mcwi |
urine total protein excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
total urine protein amount |
female |
80.0 days-99.0 days |
20 |
|
|
63.79 |
mg/d |
6.53 |
29.18 |
automated urine total protein analysis |
|
|
|
|
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52702 |
482 |
| SS-Chr 13BN/Mcwi |
urine sodium excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine sodium amount |
male |
80.0 days-99.0 days |
16 |
|
|
11.92 |
mEq/d |
1.33 |
5.31 |
flame atomic emission spectrometry |
|
|
|
|
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52757 |
482 |
| SS-Chr 13BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (for 18 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
urine albumin amount |
female |
84.0 days-88.0 days |
12 |
|
|
15.9 |
mg/d |
2.1 |
7.27 |
urine analysis |
|
86400 |
|
|
|
|
|
|
65203 |
15 |
| SS-Chr 13BN/Mcwi |
absolute change in blood pH |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
female |
82.0 days-99.0 days |
10 |
|
|
-0.01 |
null |
0.01 |
0.03 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14754 |
381 |
| SS-Chr 13BN/Mcwi |
absolute change in blood pH |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
male |
82.0 days-99.0 days |
7 |
|
|
-0.01 |
null |
0.01 |
0.03 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14759 |
381 |
| SS-Chr 13BN/Mcwi |
absolute change in heart rate |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (for 0.1 hours) |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
9 |
heart rate during walking-heart rate during rest |
|
56.11 |
beats/min |
9.35 |
28.04 |
vascular fluid filled catheter |
|
0 |
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
13389 |
381 |
| SS-Chr 13BN/Mcwi |
absolute change in heart rate |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (for 0.1 hours) |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
7 |
heart rate during walking-heart rate during rest |
|
59.04 |
beats/min |
10.62 |
28.1 |
vascular fluid filled catheter |
|
0 |
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
13394 |
381 |
| SS-Chr 13BN/Mcwi |
percent change in ventilation |
controlled air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
%change=VE during7-9 min hypercapnia/control during standard conditions |
|
283.39 |
% |
10.38 |
31.15 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
14210 |
381 |
| SS-Chr 13BN/Mcwi |
blood pH |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
male |
82.0 days-99.0 days |
8 |
|
|
7.54 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
17070 |
381 |
| SS-Chr 13BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood gas amount |
female |
82.0 days-99.0 days |
7 |
|
|
26.53 |
mmHg |
1.11 |
2.94 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
17255 |
381 |
| SS-Chr 13BN/Mcwi |
mammary tumor number |
7,12-dimethyltetraphene (65 mg/kg) (for 105 days) |
Adamovic T, et al., Genes Chromosomes Cancer. 2010 Nov;49(11):1035-45 |
mammary gland integrity trait |
female |
152.0 days-162.0 days |
13 |
|
|
5.33 |
null |
1.21 |
4.38 |
necropsy |
|
0 |
DMBA oral gavage |
105 |
days |
necropsy |
|
|
11501 |
86 |
| SS-Chr 13BN/Mcwi |
absolute change in blood pH |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
female |
82.0 days-99.0 days |
7 |
|
|
0.07 |
null |
0.01 |
0.03 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19799 |
381 |
| SS-Chr 13BN/Mcwi |
mean arterial blood pressure |
control condition |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
7 |
|
|
114.2 |
mmHg |
5.68 |
15.03 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19880 |
381 |
| SS-Chr 13BN/Mcwi |
heart rate |
control condition |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
10 |
|
|
430.23 |
beats/min |
12.19 |
38.53 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20936 |
381 |
| SS-Chr 13BN/Mcwi |
percent change in respiration rate |
controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
10 |
|
|
129.51 |
% |
5.08 |
16.08 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
53761 |
381 |
| SS-Chr 13BN/Mcwi |
percent change in tidal volume |
controlled air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
|
|
123.97 |
% |
10.12 |
32.0 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
53893 |
381 |
| SS-Chr 13BN/Mcwi |
percent change in tidal volume |
controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
115.14 |
% |
4.7 |
14.1 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
54001 |
381 |
| SS-Chr 13BN/Mcwi |
mean arterial blood pressure |
resting on treadmill (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
arterial blood pressure trait |
female |
82.0 days-99.0 days |
10 |
|
|
98.46 |
mmHg |
2.78 |
8.8 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20043 |
381 |
| SS-Chr 13BN/Mcwi |
blood pH |
control condition |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
male |
82.0 days-99.0 days |
8 |
|
|
7.47 |
null |
0.01 |
0.03 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20645 |
381 |
| SS-Chr 13BN/Mcwi |
absolute change in partial pressure of blood carbon dioxide |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82.0 days-99.0 days |
7 |
|
|
-7.11 |
mmHg |
1.15 |
3.04 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19647 |
381 |
| SS-Chr 13BN/Mcwi |
heart rate |
resting on treadmill (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
heart pumping trait |
male |
82.0 days-99.0 days |
7 |
|
|
387.5 |
beats/min |
16.73 |
44.27 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
17740 |
381 |
| SS-Chr 13BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
10 |
|
|
96.1 |
breaths/min |
5.14 |
16.26 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18417 |
381 |
| SS-Chr 13BN/Mcwi |
serum alkaline phosphatase activity level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
female |
77.0 days-91.0 days |
12 |
|
|
145.25 |
U/l |
7.61 |
26.38 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36386 |
401 |
| SS-Chr 13BN/Mcwi |
serum alkaline phosphatase activity level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood alkaline phosphatase amount |
male |
77.0 days-91.0 days |
11 |
|
|
209.64 |
U/l |
9.25 |
30.67 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36391 |
401 |
| SS-Chr 13BN/Mcwi |
blood lymphocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
11 |
|
|
5.85 |
x 1000 cells/ul |
0.51 |
1.68 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36912 |
401 |
| SS-Chr 13BN/Mcwi |
mean corpuscular hemoglobin concentration |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
11 |
|
|
32.36 |
g/dl |
0.08 |
0.27 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37371 |
401 |
| SS-Chr 13BN/Mcwi |
minute ventilation |
controlled air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
43.89 |
ml/min |
6.71 |
20.12 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18674 |
381 |
| SS-Chr 13BN/Mcwi |
heart rate |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
heart pumping trait |
female |
82.0 days-99.0 days |
10 |
|
|
380.7 |
beats/min |
11.99 |
37.92 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
17518 |
381 |
| SS-Chr 13BN/Mcwi |
serum sodium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood sodium amount |
female |
77.0 days-91.0 days |
12 |
|
|
145.25 |
mmol/l |
0.7 |
2.42 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
36524 |
401 |
| SS-Chr 13BN/Mcwi |
percent change in ventilation |
controlled air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
9 |
%change=VE during 2-3 min hypercapnia/control during standard conditions |
|
292.23 |
% |
23.61 |
70.82 |
stop flow air displacement plethysmography |
|
0 |
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19218 |
381 |
| SS-Chr 13BN/Mcwi |
absolute change in partial pressure of blood oxygen |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood oxygen amount |
male |
82.0 days-99.0 days |
8 |
|
|
-53.6 |
mmHg |
2.04 |
5.77 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19485 |
381 |
| SS-Chr 13BN/Mcwi |
minute ventilation |
controlled air oxygen content (12 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
38.81 |
ml/min |
5.79 |
17.36 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20220 |
381 |
| SS-Chr 13BN/Mcwi |
left ventricular diastolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
8 |
|
|
4.62 |
mmHg |
0.38 |
1.06 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49184 |
461 |
| SS-Chr 13BN/Mcwi |
heart left ventricle infarction weight to total heart left ventricle weight ratio |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) |
PhysGen Cardiac data |
heart left ventricle integrity trait |
male |
49.0 days-63.0 days |
17 |
|
|
24.77 |
% |
3.32 |
13.69 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49408 |
461 |
| SS-Chr 13BN/Mcwi |
heart left ventricle infarction weight to total heart left ventricle weight ratio |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) |
PhysGen Cardiac data |
heart left ventricle integrity trait |
female |
49.0 days-63.0 days |
19 |
|
|
13.96 |
% |
2.84 |
12.36 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49705 |
461 |
| SS-Chr 13BN/Mcwi |
left ventricular systolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
17 |
|
|
96.55 |
mmHg |
5.07 |
20.9 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49900 |
461 |
| SS-Chr 13BN/Mcwi |
mean corpuscular volume |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
male |
77.0 days-91.0 days |
11 |
|
|
60.64 |
fl |
0.61 |
2.03 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38757 |
401 |
| SS-Chr 13BN/Mcwi |
serum bicarbonate level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
female |
77.0 days-91.0 days |
12 |
|
|
15.0 |
mmol/l |
0.78 |
2.7 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42069 |
401 |
| SS-Chr 13BN/Mcwi |
serum bicarbonate level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77.0 days-91.0 days |
11 |
|
|
14.0 |
mmol/l |
0.99 |
3.29 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42074 |
401 |
| SS-Chr 13BN/Mcwi |
hematocrit |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
female |
77.0 days-91.0 days |
12 |
|
|
55.92 |
% |
0.58 |
2.03 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38998 |
401 |
| SS-Chr 13BN/Mcwi |
serum aspartate aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood aspartate transaminase amount |
female |
77.0 days-91.0 days |
12 |
|
|
79.08 |
U/l |
6.11 |
21.16 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42451 |
401 |
| SS-Chr 13BN/Mcwi |
percent change in respiration rate |
controlled air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
10 |
|
|
130.36 |
% |
11.38 |
35.98 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
54334 |
381 |
| SS-Chr 13BN/Mcwi |
percent change in tidal volume |
controlled air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
9 |
|
|
149.71 |
% |
6.49 |
19.47 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
54433 |
381 |
| SS-Chr 13BN/Mcwi |
mean corpuscular hemoglobin concentration |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
11 |
|
|
32.57 |
g/dl |
0.33 |
1.1 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39789 |
401 |
| SS-Chr 13BN/Mcwi |
blood neutrophil count |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
male |
77.0 days-91.0 days |
11 |
|
|
0.69 |
x 1000 cells/ul |
0.1 |
0.32 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43236 |
401 |
| SS-Chr 13BN/Mcwi |
blood hemoglobin level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
12 |
|
|
14.03 |
g/dl |
0.15 |
0.51 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40136 |
401 |
| SS-Chr 13BN/Mcwi |
serum potassium level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77.0 days-91.0 days |
12 |
|
|
4.15 |
mmol/l |
0.1 |
0.34 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43361 |
401 |
| SS-Chr 13BN/Mcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
controlled air oxygen content (12 %) (for 14 days) then methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
female |
77.0 days-91.0 days |
12 |
|
|
1.45 |
mg/kg |
0.3 |
1.05 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58913 |
526 |
| SS-Chr 13BN/Mcwi |
percent change in respiration rate |
controlled air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
9 |
|
|
186.93 |
% |
11.56 |
34.69 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
53642 |
381 |
| SS-Chr 13BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
female |
77.0 days-91.0 days |
12 |
|
|
0.12 |
x 1000 cells/ul |
0.01 |
0.04 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40328 |
401 |
| SS-Chr 13BN/Mcwi |
blood monocyte count |
control condition (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77.0 days-91.0 days |
11 |
|
|
0.24 |
x 1000 cells/ul |
0.05 |
0.17 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40337 |
401 |
| SS-Chr 13BN/Mcwi |
serum globulin level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood globulin amount |
male |
77.0 days-91.0 days |
11 |
|
|
2.85 |
g/dl |
0.05 |
0.15 |
standard blood chemistry panel |
|
|
|
|
|
|
replaced obsolete serum globulin level term, 1/19/2016 |
Moms and pups used in studies were fed Teklad |
40562 |
401 |
| SS-Chr 13BN/Mcwi |
calculated pulmonary vascular resistance normalized to body weight |
controlled air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77.0 days-91.0 days |
10 |
|
|
0.16 |
mmHg x min x kg x ml-1 |
0.01 |
0.02 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59559 |
526 |
| SS-Chr 13BN/Mcwi |
blood hemoglobin level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
male |
77.0 days-91.0 days |
11 |
|
|
18.63 |
g/dl |
0.43 |
1.43 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37980 |
401 |
| SS-Chr 13BN/Mcwi |
serum potassium level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
female |
77.0 days-91.0 days |
12 |
|
|
4.97 |
mmol/l |
0.19 |
0.66 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38073 |
401 |
| SS-Chr 13BN/Mcwi |
serum potassium level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood potassium amount |
male |
77.0 days-91.0 days |
11 |
|
|
5.65 |
mmol/l |
0.15 |
0.49 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38078 |
401 |
| SS-Chr 13BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
female |
77.0 days-91.0 days |
12 |
|
|
159.42 |
mg/dl |
5.52 |
19.13 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41228 |
401 |
| SS-Chr 13BN/Mcwi |
blood lymphocyte count |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
lymphocyte quantity |
male |
77.0 days-91.0 days |
11 |
|
|
5.1 |
x 1000 cells/ul |
0.61 |
2.04 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41515 |
401 |
| SS-Chr 13BN/Mcwi |
blood eosinophil count |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
eosinophil quantity |
male |
77.0 days-91.0 days |
11 |
|
|
0.04 |
x 1000 cells/ul |
0.01 |
0.05 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41659 |
401 |
| SS-Chr 13BN/Mcwi |
serum urea nitrogen level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood urea nitrogen amount |
male |
77.0 days-91.0 days |
11 |
|
|
16.0 |
mg/dl |
0.7 |
2.32 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41795 |
401 |
| SS-Chr 13BN/Mcwi |
serum glucose level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77.0 days-91.0 days |
11 |
|
|
151.09 |
mg/dl |
5.96 |
19.77 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38542 |
401 |
| SS-Chr 13BN/Mcwi |
mean corpuscular volume |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte size trait |
female |
77.0 days-91.0 days |
12 |
|
|
59.55 |
fl |
0.28 |
0.97 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38681 |
401 |
| SS-Chr 13BN/Mcwi |
heart rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49.0 days-63.0 days |
19 |
|
|
244.69 |
beats/min |
7.41 |
32.28 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47594 |
461 |
| SS-Chr 13BN/Mcwi |
percent change in left ventricular developed pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
13 |
post-ischemic value/pre-ischemic value x 100% |
|
32.27 |
% |
6.9 |
24.87 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
48539 |
461 |
| SS-Chr 13BN/Mcwi |
maximum contractile force per wet weight of aorta |
controlled sodium content diet (4 %) (for 21 days) then potassium ion (80 mmol/l) (for 0.2 hours) and phenylephrine (10 umol/l) (for 0.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70.0 days-84.0 days |
7 |
|
|
1.0 |
g/mg |
0.07 |
0.18 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57368 |
522 |
| SS-Chr 13BN/Mcwi |
methylene blue metabolism-surface area product after auto-oxidation |
controlled air oxygen content (12 %) (for 14 days) then methylene blue (10 umol/l) (between 0 and 0 hours) then sample resting period (for 0.1 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77.0 days-91.0 days |
12 |
|
|
14.98 |
ml/min/kg |
0.3 |
1.06 |
isolated perfused lung vascular effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57605 |
526 |
| SS-Chr 13BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
female |
70.0 days-84.0 days |
11 |
|
|
-7.71 |
null |
0.05 |
0.17 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
55300 |
522 |
| SS-Chr 13BN/Mcwi |
partial pressure of blood oxygen |
resting on treadmill (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
blood oxygen amount |
female |
82.0 days-99.0 days |
10 |
|
|
111.75 |
mmHg |
3.74 |
11.83 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16394 |
381 |
| SS-Chr 13BN/Mcwi |
concentration of sodium nitroprusside at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then sodium nitroprusside (0-3 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
9 |
|
|
0.07 |
10E-7mol/l |
0.02 |
0.05 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55746 |
522 |
| SS-Chr 13BN/Mcwi |
body weight |
control condition (for 14 days) |
PhysGen Lung data |
body mass |
female |
77.0 days-91.0 days |
12 |
|
|
187.6 |
g |
4.3 |
14.8 |
whole body digital scale |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58372 |
526 |
| SS-Chr 13BN/Mcwi |
methylene blue metabolism-surface area product without auto-oxidation |
methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77.0 days-91.0 days |
10 |
|
|
20.5 |
ml/min/kg |
1.26 |
4.0 |
isolated perfused lung vascular effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58657 |
526 |
| SS-Chr 13BN/Mcwi |
methylene blue metabolism-surface area product without auto-oxidation |
methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77.0 days-91.0 days |
10 |
|
|
13.84 |
ml/min/kg |
0.79 |
2.49 |
isolated perfused lung vascular effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58666 |
526 |
| SS-Chr 13BN/Mcwi |
concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70.0 days-84.0 days |
10 |
|
|
0.01 |
umol/l |
0.0 |
0.01 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
54940 |
522 |
| SS-Chr 13BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
female |
77.0 days-91.0 days |
11 |
|
|
0.4 |
null |
0.01 |
0.05 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58740 |
526 |
| SS-Chr 13BN/Mcwi |
heart right ventricle weight to left ventricle weight ratio |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
heart right ventricle mass |
male |
77.0 days-91.0 days |
11 |
|
|
0.42 |
null |
0.02 |
0.06 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58745 |
526 |
| SS-Chr 13BN/Mcwi |
concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
9 |
|
|
1.93 |
E-7mole |
0.25 |
0.75 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
56554 |
522 |
| SS-Chr 13BN/Mcwi |
methylene blue metabolism-surface area product after auto-oxidation |
methylene blue (10 umol/l) (between 0 and 0 hours) then sample resting period (for 0.1 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77.0 days-91.0 days |
10 |
|
|
9.56 |
ml/min/kg |
0.63 |
1.98 |
isolated perfused lung vascular effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
60037 |
526 |
| SS-Chr 13BN/Mcwi |
tidal volume |
controlled air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
0.45 |
ml |
0.03 |
0.1 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
17382 |
381 |
| SS-Chr 13BN/Mcwi |
partial pressure of blood carbon dioxide (Pco2) |
control condition |
PhysGen Respiratory data |
blood carbon dioxide amount |
male |
82.0 days-99.0 days |
8 |
|
|
33.0 |
mmHg |
0.7 |
1.98 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16089 |
381 |
| SS-Chr 13BN/Mcwi |
left ventricular diastolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
9 |
|
|
57.34 |
mmHg |
2.82 |
8.46 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47708 |
461 |
| SS-Chr 13BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
female |
49.0 days-63.0 days |
10 |
|
|
156.6 |
g |
4.0 |
12.7 |
whole body digital scale |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47838 |
461 |
| SS-Chr 13BN/Mcwi |
body weight |
control condition |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
18 |
|
|
216.2 |
g |
6.8 |
28.8 |
whole body digital scale |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47847 |
461 |
| SS-Chr 13BN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
19 |
|
|
6.62 |
ml/min/g |
0.27 |
1.18 |
isolated perfused heart effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
44725 |
461 |
| SS-Chr 13BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
17 |
|
|
10.89 |
ml/min/g |
0.46 |
1.89 |
isolated perfused heart effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
46882 |
461 |
| SS-Chr 13BN/Mcwi |
heart weight to body weight ratio |
control condition |
PhysGen Cardiac data |
heart mass |
male |
49.0 days-63.0 days |
18 |
|
|
4.42 |
g/kg |
0.14 |
0.59 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47025 |
461 |
| SS-Chr 13BN/Mcwi |
heart contraction pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
female |
49.0 days-63.0 days |
10 |
|
|
49.4 |
mmHg |
2.17 |
6.87 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
48040 |
461 |
| SS-Chr 13BN/Mcwi |
heart contraction pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
male |
49.0 days-63.0 days |
17 |
|
|
48.59 |
mmHg |
3.63 |
14.95 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
48045 |
461 |
| SS-Chr 13BN/Mcwi |
heart rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49.0 days-63.0 days |
17 |
|
|
208.04 |
beats/min |
9.84 |
40.59 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
45160 |
461 |
| SS-Chr 13BN/Mcwi |
percent change in heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49.0 days-63.0 days |
17 |
post-ischemic value/pre-ischemic value x 100% |
|
86.33 |
% |
2.5 |
10.3 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
48418 |
461 |
| SS-Chr 13BN/Mcwi |
extensor digitorum longus muscle weight to body weight ratio |
control condition (for 7 days) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56.0 days-70.0 days |
15 |
EDL/BW |
|
0.42 |
mg/g |
0.01 |
0.04 |
ex vivo method |
|
0.0 |
|
|
|
|
TA or EDL muscle weight body weight ratio |
|
99033 |
2198 |
| SS-Chr 13BN/Mcwi |
partial pressure of blood oxygen |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
blood oxygen amount |
male |
82.0 days-99.0 days |
7 |
|
|
116.05 |
mmHg |
5.46 |
14.44 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
15044 |
381 |
| SS-Chr 13BN/Mcwi |
blood pH |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (for 0.1 hours) |
PhysGen Respiratory data |
blood acidity-alkalinity balance trait |
male |
82.0 days-99.0 days |
7 |
|
|
7.45 |
null |
0.01 |
0.02 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
Conversion period. Moms had mixed diet, Dyets and Teklad, for 3-4 weeks. Whatever Mom was fed, so were pups. Whatever pups were fed in the barrier, they continued with through the study. Possible maternal influence on pups estimated at 10 weeks |
14598 |
381 |
| SS-Chr 13BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
arterial blood pressure trait |
female |
80.0 days-99.0 days |
17 |
|
|
143.21 |
mmHg |
1.44 |
5.93 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52851 |
482 |
| SS-Chr 13BN/Mcwi |
plasma renin activity level |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
renin activity |
male |
80.0 days-99.0 days |
17 |
|
|
0.43 |
ng/ml/h |
0.09 |
0.35 |
radioimmunoassay |
|
|
|
|
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52461 |
482 |
| SS-Chr 13BN/Mcwi |
urine albumin excretion rate |
controlled sodium content diet (8 %) (between 19 and 22 days) |
PhysGen Renal B data |
urine albumin amount |
female |
80.0 days-99.0 days |
20 |
|
|
5.13 |
mg/d |
0.94 |
4.22 |
radioimmunoassay |
|
|
|
|
|
|
|
Moms were fed Teklad, pups used in studies were fed Dyets |
52602 |
482 |
| SS-Chr 13BN/Mcwi |
percent change in tidal volume |
controlled air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
9 |
|
|
155.43 |
% |
6.54 |
19.61 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
54093 |
381 |
| SS-Chr 13BN/Mcwi |
percent change in respiration rate |
controlled air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
female |
82.0 days-99.0 days |
9 |
|
|
169.15 |
% |
13.11 |
39.34 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
54227 |
381 |
| SS-Chr 13BN/Mcwi |
mean arterial blood pressure |
controlled sodium content diet (8 %) (between 16 and 19 days) |
Moreno et al. Physiol Genomics 2007 Oct 22;31(2):228-35. Epub 2007 Jun 12. |
arterial blood pressure trait |
male |
86.0 days-89.0 days |
12 |
|
|
142.0 |
mmHg |
1.3 |
4.5 |
vascular fluid filled catheter |
left femoral artery |
14400 |
|
|
|
on 3 consecutive days |
|
|
5404 |
15 |
| SS-Chr 13BN/Mcwi |
percent change in ventilation |
controlled air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
%change=VE during 2-3 min hypoxia/control during standard conditions |
|
158.2 |
% |
14.02 |
44.32 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
13687 |
381 |
| SS-Chr 13BN/Mcwi |
absolute change in mean arterial blood pressure |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
arterial blood pressure trait |
male |
82.0 days-99.0 days |
7 |
|
|
19.8 |
mmHg |
2.02 |
5.35 |
vascular fluid filled catheter |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20726 |
381 |
| SS-Chr 13BN/Mcwi |
percent change in tidal volume |
controlled air oxygen content (12 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
120.11 |
% |
6.77 |
20.3 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
53900 |
381 |
| SS-Chr 13BN/Mcwi |
absolute change in partial pressure of blood carbon dioxide |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
blood carbon dioxide amount |
female |
82.0 days-99.0 days |
10 |
|
|
-2.47 |
mmHg |
0.67 |
2.12 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20077 |
381 |
| SS-Chr 13BN/Mcwi |
body temperature |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (for 0.1 hours) then running on treadmill (1.6 m/min) (for 0.1 hours) |
PhysGen Respiratory data |
body temperature trait |
female |
82.0 days-99.0 days |
10 |
|
|
38.4 |
degrees C |
0.16 |
0.52 |
digital rectal thermometry |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
17637 |
381 |
| SS-Chr 13BN/Mcwi |
respiration rate |
controlled air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
9 |
|
|
164.19 |
breaths/min |
4.46 |
13.38 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16923 |
381 |
| SS-Chr 13BN/Mcwi |
respiration rate |
control condition |
PhysGen Respiratory data |
respiratory function trait |
male |
82.0 days-99.0 days |
9 |
|
|
102.02 |
breaths/min |
5.84 |
17.52 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18422 |
381 |
| SS-Chr 13BN/Mcwi |
serum total cholesterol level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77.0 days-91.0 days |
12 |
|
|
81.75 |
mg/dl |
2.57 |
8.9 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37104 |
401 |
| SS-Chr 13BN/Mcwi |
serum total cholesterol level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77.0 days-91.0 days |
11 |
|
|
87.55 |
mg/dl |
2.44 |
8.1 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37109 |
401 |
| SS-Chr 13BN/Mcwi |
percent change in ventilation |
controlled air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
10 |
%change=VE during7-9 min hypercapnia/control during standard conditions |
|
151.29 |
% |
14.46 |
45.73 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
18550 |
381 |
| SS-Chr 13BN/Mcwi |
percent change in ventilation |
controlled air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
%change=VE during 2-3 min hypercapnia/control during standard conditions |
|
290.72 |
% |
5.58 |
16.74 |
stop flow air displacement plethysmography |
|
0 |
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
19223 |
381 |
| SS-Chr 13BN/Mcwi |
partial pressure of blood oxygen |
controlled air oxygen content (12 %) (for 0.1 hours) |
PhysGen Respiratory data |
blood oxygen amount |
male |
82.0 days-99.0 days |
8 |
|
|
54.83 |
mmHg |
1.79 |
5.06 |
automated blood gas analysis using a Bayer analyzer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
20497 |
381 |
| SS-Chr 13BN/Mcwi |
heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49.0 days-63.0 days |
17 |
|
|
218.66 |
beats/min |
9.26 |
38.19 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
48957 |
461 |
| SS-Chr 13BN/Mcwi |
body weight |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Cardiac data |
body mass |
male |
49.0 days-63.0 days |
19 |
|
|
190.9 |
g |
6.8 |
29.7 |
whole body digital scale |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49552 |
461 |
| SS-Chr 13BN/Mcwi |
heart left ventricle infarction weight to total heart left ventricle weight ratio |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 3 hours) |
PhysGen Cardiac data |
heart left ventricle integrity trait |
male |
49.0 days-63.0 days |
19 |
|
|
13.36 |
% |
3.62 |
15.79 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
49710 |
461 |
| SS-Chr 13BN/Mcwi |
heart contraction pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
male |
49.0 days-63.0 days |
19 |
|
|
46.05 |
mmHg |
3.66 |
15.94 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
50009 |
461 |
| SS-Chr 13BN/Mcwi |
time to onset of heart contraction |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart muscle contractility trait |
female |
49.0 days-63.0 days |
10 |
|
|
964.6 |
s |
33.28 |
105.25 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
50126 |
461 |
| SS-Chr 13BN/Mcwi |
blood neutrophil count |
control condition (for 14 days) |
PhysGen Biochemistry data |
neutrophil quantity |
female |
77.0 days-91.0 days |
12 |
|
|
0.48 |
x 1000 cells/ul |
0.04 |
0.14 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38930 |
401 |
| SS-Chr 13BN/Mcwi |
serum albumin level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood albumin amount |
female |
77.0 days-91.0 days |
12 |
|
|
4.18 |
g/dl |
0.03 |
0.11 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42240 |
401 |
| SS-Chr 13BN/Mcwi |
serum chloride level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood chloride amount |
female |
77.0 days-91.0 days |
12 |
|
|
110.0 |
mmol/l |
1.24 |
4.29 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39124 |
401 |
| SS-Chr 13BN/Mcwi |
mean corpuscular hemoglobin |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
12 |
|
|
20.01 |
pg |
0.19 |
0.65 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42552 |
401 |
| SS-Chr 13BN/Mcwi |
plasma creatinine level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77.0 days-91.0 days |
11 |
|
|
0.2 |
mg/dl |
0.02 |
0.06 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42689 |
401 |
| SS-Chr 13BN/Mcwi |
plasma creatinine level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood creatinine amount |
male |
77.0 days-91.0 days |
11 |
|
|
0.3 |
mg/dl |
0.01 |
0.04 |
automated plasma creatinine analysis |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39588 |
401 |
| SS-Chr 13BN/Mcwi |
blood monocyte count |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
monocyte quantity |
male |
77.0 days-91.0 days |
11 |
|
|
0.31 |
x 1000 cells/ul |
0.08 |
0.27 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
39686 |
401 |
| SS-Chr 13BN/Mcwi |
serum bicarbonate level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood bicarbonate amount |
male |
77.0 days-91.0 days |
11 |
|
|
22.18 |
mmol/l |
0.69 |
2.27 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
43033 |
401 |
| SS-Chr 13BN/Mcwi |
percent change in tidal volume |
controlled air carbon dioxide content (7 %) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
167.26 |
% |
5.73 |
17.19 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
54440 |
381 |
| SS-Chr 13BN/Mcwi |
body weight |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
body mass |
male |
77.0 days-91.0 days |
11 |
|
|
255.3 |
g |
5.7 |
18.9 |
whole body digital scale |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59074 |
526 |
| SS-Chr 13BN/Mcwi |
serum alanine aminotransferase activity level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
77.0 days-91.0 days |
12 |
|
|
43.25 |
U/l |
1.55 |
5.36 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
40721 |
401 |
| SS-Chr 13BN/Mcwi |
dose of methacholine at which pulmonary conductance is half its pretreatment value |
methacholine (0-11.06 mg/kg) and drug dose time series (for 0.2 hours) |
PhysGen Lung data |
pulmonary ventilation trait |
male |
77.0 days-91.0 days |
11 |
|
|
1.85 |
mg/kg |
0.4 |
1.32 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59207 |
526 |
| SS-Chr 13BN/Mcwi |
hematocrit |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
11 |
|
|
57.16 |
% |
1.1 |
3.64 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59269 |
526 |
| SS-Chr 13BN/Mcwi |
fractional change in blood vessel diameter per unit change in intravascular pressure |
Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
blood vessel distensibility trait |
female |
77.0 days-91.0 days |
11 |
|
|
0.05 |
mmHg-1 |
0.0 |
0.01 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59392 |
526 |
| SS-Chr 13BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
female |
77.0 days-91.0 days |
12 |
|
|
1.02 |
g/kg |
0.02 |
0.05 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59488 |
526 |
| SS-Chr 13BN/Mcwi |
lung dry weight to body weight ratio |
control condition (for 14 days) |
PhysGen Lung data |
lung mass |
male |
77.0 days-91.0 days |
11 |
|
|
0.84 |
g/kg |
0.02 |
0.07 |
digital scale post excision weight measurement |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59497 |
526 |
| SS-Chr 13BN/Mcwi |
serum alanine aminotransferase activity level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood alanine transaminase amount |
female |
77.0 days-91.0 days |
12 |
|
|
40.42 |
U/l |
2.02 |
6.99 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37741 |
401 |
| SS-Chr 13BN/Mcwi |
blood hemoglobin level |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
blood hemoglobin amount |
female |
77.0 days-91.0 days |
12 |
|
|
17.91 |
g/dl |
0.28 |
0.96 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
37975 |
401 |
| SS-Chr 13BN/Mcwi |
serum glucose level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood glucose amount |
male |
77.0 days-91.0 days |
11 |
|
|
161.18 |
mg/dl |
5.07 |
16.82 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
41237 |
401 |
| SS-Chr 13BN/Mcwi |
plasma anion gap |
controlled air oxygen content (12 %) (for 14 days) |
PhysGen Biochemistry data |
ion homeostasis trait |
female |
77.0 days-91.0 days |
12 |
|
|
25.25 |
mmol/l |
1.91 |
6.62 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38268 |
401 |
| SS-Chr 13BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
female |
77.0 days-91.0 days |
12 |
|
|
96.75 |
mg/dl |
1.53 |
5.29 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38467 |
401 |
| SS-Chr 13BN/Mcwi |
serum total cholesterol level |
control condition (for 14 days) |
PhysGen Biochemistry data |
blood cholesterol amount |
male |
77.0 days-91.0 days |
11 |
|
|
81.09 |
mg/dl |
2.11 |
7.01 |
standard blood chemistry panel |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
38476 |
401 |
| SS-Chr 13BN/Mcwi |
red blood cell count |
control condition (for 14 days) |
PhysGen Biochemistry data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
11 |
|
|
7.53 |
x 10E6 cells/ul |
0.09 |
0.29 |
automated blood cell counting method |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
42012 |
401 |
| SS-Chr 13BN/Mcwi |
left ventricular diastolic blood pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
17 |
|
|
44.55 |
mmHg |
5.3 |
21.87 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
46429 |
461 |
| SS-Chr 13BN/Mcwi |
time to peak heart contraction |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) |
PhysGen Cardiac data |
heart pumping trait |
male |
49.0 days-63.0 days |
17 |
|
|
1162.88 |
s |
56.55 |
233.16 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
46560 |
461 |
| SS-Chr 13BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49.0 days-63.0 days |
19 |
|
|
0.27 |
IU/g |
0.04 |
0.16 |
isolated perfused heart effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
47477 |
461 |
| SS-Chr 13BN/Mcwi |
hematocrit |
control condition (for 14 days) |
PhysGen Lung data |
erythrocyte quantity |
male |
77.0 days-91.0 days |
11 |
|
|
43.25 |
% |
0.47 |
1.57 |
microhematocrit tube assay with visual assessment |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57530 |
526 |
| SS-Chr 13BN/Mcwi |
minute ventilation |
control condition |
PhysGen Respiratory data |
pulmonary ventilation trait |
male |
82.0 days-99.0 days |
9 |
|
|
26.06 |
ml/min |
1.54 |
4.63 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16159 |
381 |
| SS-Chr 13BN/Mcwi |
absolute change in partial pressure of blood oxygen |
resting on treadmill (for 0.1 hours) then walking on treadmill (0.8 m/min) (between 0.1 and 0.1 hours) |
PhysGen Respiratory data |
blood oxygen amount |
female |
82.0 days-99.0 days |
10 |
|
|
4.36 |
mmHg |
2.46 |
7.77 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16280 |
381 |
| SS-Chr 13BN/Mcwi |
body weight |
controlled sodium content diet (4 %) (for 21 days) |
PhysGen Vascular data |
body mass |
female |
70.0 days-84.0 days |
16 |
|
|
215.8 |
g |
4.0 |
15.8 |
whole body digital scale |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55205 |
522 |
| SS-Chr 13BN/Mcwi |
tidal volume |
controlled air carbon dioxide content (7 %) (between 0 and 0.1 hours) |
PhysGen Respiratory data |
pulmonary ventilation trait |
female |
82.0 days-99.0 days |
9 |
|
|
0.45 |
ml |
0.03 |
0.09 |
stop flow air displacement plethysmography |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
16480 |
381 |
| SS-Chr 13BN/Mcwi |
body weight |
control condition (for 21 days) |
PhysGen Vascular data |
body mass |
male |
70.0 days-84.0 days |
9 |
|
|
260.5 |
g |
24.3 |
73.0 |
whole body digital scale |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55448 |
522 |
| SS-Chr 13BN/Mcwi |
logarithm of the concentration of acetylcholine at which the reduction in force during dilation of a blood vessel is half the maximum value (Log EC50) |
phenylephrine (1 umol/l) (for 0.2 hours) then acetylcholine (0-30 umol/l) and drug dose time series (for 1 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
9 |
|
|
-6.57 |
null |
0.08 |
0.24 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
55659 |
522 |
| SS-Chr 13BN/Mcwi |
logarithm of the concentration of phenylephrine at which the force of blood vessel contraction is half the maximum value (Log EC50) |
controlled sodium content diet (4 %) (for 21 days) then phenylephrine (0-300 umol/l) and drug dose time series (for 1.2 hours) |
PhysGen Vascular data |
vasoconstriction trait |
male |
70.0 days-84.0 days |
10 |
|
|
-7.97 |
null |
0.09 |
0.28 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
EC50 value is moles/liter |
Moms and pups used in studies were fed Teklad |
56139 |
522 |
| SS-Chr 13BN/Mcwi |
fractional change in blood vessel diameter per unit change in intravascular pressure |
controlled air oxygen content (12 %) (for 14 days) then Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
blood vessel distensibility trait |
female |
77.0 days-91.0 days |
12 |
|
|
0.04 |
mmHg-1 |
0.0 |
0.01 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
58496 |
526 |
| SS-Chr 13BN/Mcwi |
methylene blue to FAPGG metabolism-surface area product ratio |
methylene blue (10 umol/l) (between 0 and 0 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
male |
77.0 days-91.0 days |
10 |
|
|
0.43 |
null |
0.03 |
0.08 |
isolated perfused lung vascular effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59815 |
526 |
| SS-Chr 13BN/Mcwi |
calculated pulmonary vascular resistance normalized to body weight |
Kreb's solution perfusate (between 0.2 and 0.2 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77.0 days-91.0 days |
11 |
|
|
0.11 |
mmHg x min x kg x ml-1 |
0.0 |
0.01 |
fluid-filled catheter with pressure transducer in isolated perfused lung |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
59922 |
526 |
| SS-Chr 13BN/Mcwi |
methylene blue metabolism-surface area product after auto-oxidation |
methylene blue (10 umol/l) (between 0 and 0 hours) then sample resting period (for 0.1 hours) |
PhysGen Lung data |
pulmonary blood flow trait |
female |
77.0 days-91.0 days |
10 |
|
|
14.35 |
ml/min/kg |
0.86 |
2.7 |
isolated perfused lung vascular effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
60028 |
526 |
| SS-Chr 13BN/Mcwi |
hypoxia-induced blood vessel dilation expressed as percent reduction of the force generated in a pre-constricted blood vessel |
phenylephrine (1 umol/l) then controlled oxygen content physiological salt solution perfusate (95 %) (for 0.2 hours) then controlled oxygen content physiological salt solution perfusate (10 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (5 %) (for 0.3 hours) then controlled oxygen content physiological salt solution perfusate (0 %) (for 0.3 hours) |
PhysGen Vascular data |
vasodilation trait |
male |
70.0 days-84.0 days |
9 |
|
|
52.0 |
% |
6.28 |
18.83 |
wire myography using a Digi-Med tissue force analysis system with force transducer |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
57179 |
522 |
| SS-Chr 13BN/Mcwi |
left ventricular systolic blood pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
male |
49.0 days-63.0 days |
17 |
|
|
99.59 |
mmHg |
5.08 |
20.96 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
44827 |
461 |
| SS-Chr 13BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
17 |
post-ischemic value/pre-ischemic value x 100% |
|
56.56 |
% |
3.07 |
12.66 |
isolated perfused heart effluent collection |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
46078 |
461 |
| SS-Chr 13BN/Mcwi |
heart rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart pumping trait |
female |
49.0 days-63.0 days |
10 |
|
|
232.05 |
beats/min |
6.75 |
21.36 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
48204 |
461 |
| SS-Chr 13BN/Mcwi |
percent change in left ventricular developed pressure |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
7 |
post-ischemic value/pre-ischemic value x 100% |
|
42.87 |
% |
4.71 |
12.45 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
46326 |
461 |
| SS-Chr 13BN/Mcwi |
left ventricular developed pressure |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
heart left ventricular blood pressure trait |
female |
49.0 days-63.0 days |
18 |
|
|
58.08 |
mmHg |
4.6 |
19.52 |
balloon tipped catheter with pressure transducer in isolated perfused heart |
|
|
|
|
|
|
|
Moms and pups used in studies were fed Teklad |
45277 |
461 |
| SS-Chr 13BN/Mcwi |
body weight |
common peroneal nerve direct electrical stimulation (3 V) (for 8 hours) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
body mass |
male |
56.0 days-70.0 days |
15 |
|
|
316.4 |
g |
6.8 |
26.34 |
body weighing method |
|
0.0 |
|
|
|
|
|
|
99006 |
2198 |
| SS-Chr 13BN/Mcwi |
tibialis anterior muscle weight to body weight ratio |
common peroneal nerve direct electrical stimulation (3 V) (for 8 hours) |
Stodola TJ, et al., Physiol Genomics. 2011 Jul 14;43(13):808-17. doi: 10.1152/physiolgenomics.00171.2010. Epub 2011 Apr 26. |
skeletal muscle mass |
male |
56.0 days-70.0 days |
15 |
TA/BW |
|
1.85 |
mg/g |
0.04 |
0.15 |
ex vivo method |
|
0.0 |
|
|
|
|
TA or EDL muscle weight body weight ratio |
|
99036 |
2198 |